Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy
2020 · Cell Research · 927 citations
https://doi.org/10.1038/s41422-020-00395-4
W
Weidong Han
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
463
Papers
20.2K
Citations
73
h-index
211
i10-index
Weidong Han is an academic researcher from Zhejiang Cancer Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Lymphoma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 73, co-authored 394 publications.
ORCID: 0000-0003-3207-3899Papers by this author
worksTemporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer
2021 · Nature Cancer · 451 citations
https://doi.org/10.1038/s43018-021-00292-8
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
2018 · Journal of Hematology & Oncology · 389 citations
https://doi.org/10.1186/s13045-018-0578-4
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
2017 · Protein & Cell · 304 citations
https://doi.org/10.1007/s13238-017-0440-4
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
2021 · Cellular and Molecular Immunology · 245 citations
https://doi.org/10.1038/s41423-021-00749-x
Genetically engineered T cells for cancer immunotherapy
2019 · Signal Transduction and Targeted Therapy · 238 citations
https://doi.org/10.1038/s41392-019-0070-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat